ribeard....84 million was the cash on December...now we have april....celadon is cash poor....they need the money badly....unless they got good data....if data is as poor as their cash position I can see you singing 'there is a tear in my beer '....I hope they will do well.
But they could raise some dollars if they wanted....why they did not is my point....are they optimistic or nobody was willing to buy the secondary...data may not be that bad is my conclusion...a small bet here.
thig...no.....it will be a buyout designed long ago.....CG was a problem for the execution of the scheme..now BMRN will pay couple of billion bucks plus and dominate the whole DMD space without patent issues....the day biomarin buys sarepta BMRN's stock will be up 30 percent....it will be heralded as a huge deal with big implications...and starfe is a very smart fella.
that's right....wall street is giving money away for some time now...if you know the story well you can make money..look at KYTH....the data were known for more than a year ago but they let it run only recently....same here....some impressive early results are known for some time now..the company is working hard to meet demand before final data released....the bar kinda low...I bet celadon will be fine.
Hey sudnwealth....thanks....golong is a great investor...an expert in the antibiotic space....pretty good for a civil prosecutor.....have a good day...and stay the course.
hey hwsimpsonhero....I was saying the same back in January and you got a little upset pointing out the risks.....any way, I agree....buyout at 400.
freerober,since you are good in physics answer quickly....at what temperature farenheit and celcius coincide?
hwsimpson.....I think we may have data for aacld pretty soon....as difficult to cure as the other rare diseases just smaller market....
He said they injected patients in sickle cell....not only one. and then he said: it may sound crazy but we are shooting for a cure....updates this year...to the moon Alice.
No....the reason for the time slot was that sarepta did not want to pay the fees for a regular presentation....
Tredleon,if there is anyone who really gets it,it is you.....I do not know your background but you are the smartest guy this board has ever seen...sorry starfe you come third....after greyzone.....the sarepta case reminds me of dendreon...fda delays everything until something better comes along....new competitors must be around the corner that most are unaware of....who could that be?...I am not currently a shareholder but I really pray for the best outcome.....it is not that Chris tried to blackmail the FDA using the popularity of etteplirsen...It is in my opinion that if the FDA was free of outside influence it would have approved this drug already...o tempora o mores.
Good....I am curious about the progress and possible near term news on Ccald.....that could add at least 30 bucks to the share price.....in combo with additional beta news we could see 200 dollars pps by June....and with the first patient on sickle cell cured 300 dollars...I know you think my numbers are exuberant but I call it the way I see it....by the end of the year we will get bought....what most do not comprehend is that bluebird likely will show cures on three different rare diseases....something unheard of any other company in the universe...unfortunately the buyout price will be no more than 500 bucks.
Today is before 2016..... After positive release of few sickle cell cures bluebird will be bought.....do you like 400 dollars as a buyout price or you think is not even close to its real value...come on man...is not how much the pps should be today..it is how much the company worth based on what we know...period.
Nah.....competitors like SGMOs fans use those claims about possible future side effects to instill fear....because they left in the dust.....anyone can claim anything....in between let's have some spectacular cures for people in need and some extra money in our pockets.